What are the dosage recommendations for Delta sleepinducing peptide (DSIP), from the starting dose to the maximum dose?
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
References 1.Pratley RE, Nauck M, Bailey T, et al
Prescription medications are administered once a week and provide a level of appetite control that berberine simply cannot match
39 To be clear, no study has shown BPC-157 causes cancer in humans
Injecting at too shallow an angle can result in intradermal injection (too shallow, medication stays in the skin) or the needle glancing off rather than penetrating cleanly